Increased Pro Th1 And Th17 Transcriptional Activity In Patients With Severe COVID-19

Background: COVID-19 is known to disrupt immune response and induce hyperinflammation that could potentially induce fatal outcome of the disease. Until now, it is known that interplay among cytokines is rather important for clinical presentation and outcome of COVID-19. The aim of this study was to determine transcriptional activity and functional phenotype of T cells and the relationship between pro-and anti-inflammatory cytokines and clinical parameters of COVID-19 severity. Methods: All recruited patients met criteria for COVID-19 are were divided in four groups according to disease severity. Serum levels of IL-12, IFN-gamma, IL-17 and IL-23 were measured, and flow cytometry analysis of T cells from peripheral blood was performed. Results: Significant elevation of IL-12, IFN-gamma, IL-17 and IL-23 in stage IV of the disease has been revealed. Further, strong intercorrelation between IL-12, IFN-gamma, IL-17 and IL-23 was also found in stage IV of the disease, marking augmented Th1 and Th17 response. Analyses of T cells subsets indicate a noticeable phenotype change. CD4+, but not CD8+ T cells expressed increased transcriptional activity through increased expression of Tbet and ROR gamma T, accompanied with increased percentage of IFN-gamma and IL-17 producing T cells. Conclusion: Our results pose a novel hypothesis of the underlying mechanism behind deteriorating immune response in severe cases of COVID-19.

Automated summary

This study aimed to determine the transcriptional activity and functional phenotype of T cells and the relationship between pro-and anti-inflammatory cytokines and clinical parameters of COVID-19 severity. The results showed a significant elevation of IL-12, IFN-gamma, IL-17, and IL-23 in stage IV of the disease, with a strong intercorrelation between these cytokines. CD4+ T cells displayed increased transcriptional activity and an increased percentage of IFN-gamma and IL-17 producing T cells.